Skip to content
10-Q

Quarterly Report

Q Therapeutics, Inc.

0001193125-13-442024

← back to feed
Filed
Nov 14, 2013 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2013 · Nov 14, 2013 24.94M sh
Capex Q3 2013 · Sep 30, 2013 $431.27K
Capex Q3 2013 · Sep 30, 2012 $2.36K
Operating Cash Flow Q3 2013 · Sep 30, 2013 −$17.16M
Operating Cash Flow Q3 2013 · Sep 30, 2012 −$1.62M
Stockholders Equity Q3 2013 · Sep 30, 2013 −$2.46M
Stockholders Equity Q3 2013 · Dec 31, 2012 $4.99K
Current Liabilities Q3 2013 · Sep 30, 2013 $3.04M
Current Liabilities Q3 2013 · Dec 31, 2012 $1.3M
Current Assets Q3 2013 · Sep 30, 2013 $537.17K
Current Assets Q3 2013 · Dec 31, 2012 $1.28M
Total Assets Q3 2013 · Sep 30, 2013 $574.9K
Total Assets Q3 2013 · Dec 31, 2012 $1.31M
Sga Expense Q3 2013 · Sep 30, 2013 $10.2M
Sga Expense Q3 2013 · Sep 30, 2012 $317.96K
Sga Expense Q3 2013 · Sep 30, 2012 $1.05M
Rd Expense Q3 2013 · Sep 30, 2013 $12.62M
Rd Expense Q3 2013 · Sep 30, 2012 $283.14K
Rd Expense Q3 2013 · Sep 30, 2012 $764.81K
Net Income Q3 2013 · Sep 30, 2013 −$23.26M
Net Income Q3 2013 · Sep 30, 2012 −$601.45K
Net Income Q3 2013 · Sep 30, 2012 −$1.81M
Operating Income Q3 2013 · Sep 30, 2013 −$21.42M
Operating Income Q3 2013 · Sep 30, 2012 −$601.1K
Operating Income Q3 2013 · Sep 30, 2012 −$1.81M
Gross Profit Q3 2013 · Sep 30, 2013 $1.39M
Gross Profit Q3 2013 · Sep 30, 2012 $7.23K
Cost Of Revenue Q3 2013 · Sep 30, 2013 $4.8K
Revenue Q3 2013 · Sep 30, 2013 $1.4M
Revenue Q3 2013 · Sep 30, 2012 $7.23K
Cash And Equivalents Q3 2013 · Sep 30, 2012 $1.3M
Cash And Equivalents Q3 2013 · Dec 31, 2011 $2.74M